全文获取类型
收费全文 | 122310篇 |
免费 | 6631篇 |
国内免费 | 153篇 |
专业分类
耳鼻咽喉 | 1847篇 |
儿科学 | 5388篇 |
妇产科学 | 4048篇 |
基础医学 | 17231篇 |
口腔科学 | 3090篇 |
临床医学 | 8847篇 |
内科学 | 23251篇 |
皮肤病学 | 3422篇 |
神经病学 | 9400篇 |
特种医学 | 5224篇 |
外国民族医学 | 32篇 |
外科学 | 20036篇 |
综合类 | 1627篇 |
一般理论 | 31篇 |
预防医学 | 6291篇 |
眼科学 | 3443篇 |
药学 | 8793篇 |
中国医学 | 326篇 |
肿瘤学 | 6767篇 |
出版年
2018年 | 999篇 |
2017年 | 893篇 |
2016年 | 1181篇 |
2015年 | 1342篇 |
2014年 | 1750篇 |
2013年 | 2611篇 |
2012年 | 3417篇 |
2011年 | 3497篇 |
2010年 | 2169篇 |
2009年 | 2118篇 |
2008年 | 3560篇 |
2007年 | 3810篇 |
2006年 | 3956篇 |
2005年 | 4034篇 |
2004年 | 3949篇 |
2003年 | 3802篇 |
2002年 | 3758篇 |
2001年 | 7240篇 |
2000年 | 7219篇 |
1999年 | 6075篇 |
1998年 | 1654篇 |
1997年 | 1583篇 |
1996年 | 1352篇 |
1995年 | 1279篇 |
1994年 | 1154篇 |
1993年 | 1174篇 |
1992年 | 3960篇 |
1991年 | 3772篇 |
1990年 | 3749篇 |
1989年 | 3511篇 |
1988年 | 3121篇 |
1987年 | 3056篇 |
1986年 | 2936篇 |
1985年 | 2722篇 |
1984年 | 2052篇 |
1983年 | 1679篇 |
1982年 | 985篇 |
1981年 | 959篇 |
1980年 | 800篇 |
1979年 | 1894篇 |
1978年 | 1411篇 |
1977年 | 1152篇 |
1976年 | 970篇 |
1975年 | 1211篇 |
1974年 | 1261篇 |
1973年 | 1234篇 |
1972年 | 1078篇 |
1971年 | 1007篇 |
1970年 | 901篇 |
1969年 | 802篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Epitope‐based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study 下载免费PDF全文
M. A. Khan M. U. Hossain S. M. Rakib‐Uz‐Zaman M. N. Morshed 《Scandinavian journal of immunology》2015,82(1):25-34
Ebola viruses (EBOVs) have been identified as an emerging threat in recent year as it causes severe haemorrhagic fever in human. Epitope‐based vaccine design for EBOVs remains a top priority because a mere progress has been made in this regard. Another reason is the lack of antiviral drug and licensed vaccine although there is a severe outbreak in Central Africa. In this study, we aimed to design an epitope‐based vaccine that can trigger a significant immune response as well as to prognosticate inhibitor that can bind with potential drug target sites using various immunoinformatics and docking simulation tools. The capacity to induce both humoral and cell‐mediated immunity by T cell and B cell was checked for the selected protein. The peptide region spanning 9 amino acids from 42 to 50 and the sequence TLASIGTAF were found as the most potential B and T cell epitopes, respectively. This peptide could interact with 12 HLAs and showed high population coverage up to 80.99%. Using molecular docking, the epitope was further appraised for binding against HLA molecules to verify the binding cleft interaction. In addition with this, the allergenicity of the epitopes was also evaluated. In the post‐therapeutic strategy, docking study of predicted 3D structure identified suitable therapeutic inhibitor against targeted protein. However, this computational epitope‐based peptide vaccine designing and target site prediction against EBOVs open up a new horizon which may be the prospective way in Ebola viruses research; the results require validation by in vitro and in vivo experiments. 相似文献
43.
Amrallah A. Mohammed Abdullah S. Al-Zahrani Mian U. Farooq Hafez M. Ghanem Lobna A. Abdelaziz Hani M. EL-Khatib 《Indian journal of hematology & blood transfusion》2015,31(4):439-445
Venous thromboembolism (VTE) represents one of the most important causes of morbidity and mortality in cancer patients. This investigation was undertaken to investigate the natural history of VTE in the oncology center in a tertiary care hospital. We did a retrospective study on cancer patients who presented to King Abdullah Medical city in Holly capital; a tertiary care hospital; from May 2011 to June 2013. Follow up period was calculated from time of VTE diagnosis till the last clinical visit or till patient death. Among 1,678 cancer patients, 132 (7.87 %) were diagnosed with VTE. The median patient age was 53.5 years, with female to male ratio 1.3/1. Thirty one patients (23.5 %) were diagnosed with VTE and cancer simultaneously, seventy four patients (56.1 %) were on chemotherapy and twenty eight patients (21.2 %) were on best supportive care.VTE were symptomatic in 110 patients (83.3 %) and asymptomatic in 22 patients (16.7 %). Lower limbs were the commonest site (42.4 %) with the highest incidence in patients with advanced stages (93 %). Forty nine (37 %) patients were receiving LMWH as prophylaxis. Median survival in months for patients with VTE prophylaxis versus without prophylactic, and asymptomatic versus symptomatic were (12.6 vs 6.3; p 0.12 and 9.8 vs 12.4; p 0.885, respectively). There is underutilization of thromboprophylaxis in our region, which needs more effort to reduce VTE burden. Also we need large prospective studies to clarify the impact of VTE symptoms and presentation on patient’s survival. 相似文献
44.
Retracted: Response on the author's reply to the Letter to the Editor: Contradictory data on type 1 diabetes in a recently published article ‘Risks of neurological and immune‐related diseases,including narcolepsy,after vaccination with Pandemrix’ 下载免费PDF全文
L. Andersson 《Journal of internal medicine》2015,277(2):272-273
45.
46.
47.
48.
49.
Consensus on performing skin biopsies,laboratory workup,evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft‐versus‐host disease 下载免费PDF全文
50.